Low oxygen sensing in chemoreceptor cells involves the inhibition of specific plasma membrane K + channels, suggesting that mitochondria-derived reactive oxygen species (ROS) link hypoxia to K + channel inhibition, subsequent cell depolarization and activation of neurotransmitter release. We have used several mitochondrial poisons, alone and in combination with the antioxidant N-acetylcysteine (NAC), and quantify their capacity to alter GSH/GSSG levels and glutathione redox potential (E GSH ) in rat diaphragm. Selected concentrations of mitochondrial poisons with or without NAC were tested for their capacity to activate neurotransmitter release in chemoreceptor cells and to alter ATP levels in intact rat carotid body (CB). We found that rotenone (1 M), antimycin A (0.2 g/ml) and sodium azide (5 mM) decreased E GSH ; NAC restored E GSH to control values. At those concentrations mitochondrial poisons activated neurotransmitter release from CB chemoreceptor cells and decreased CB ATP levels, NAC being ineffective to modify these responses. Additional experiments with 3-nitroprionate (5 mM), lower concentrations of rotenone and dinitrophenol revealed variable relationships between E GSH and chemoreceptor cell neurotransmitter release responses and ATP levels. These findings indicate a lack of correlation between mitochondrialgenerated modifications of E GSH and chemoreceptor cells activity. This lack of correlation renders unlikely that alteration of mitochondrial production of ROS is the physiological pathway chemoreceptor cells use to signal hypoxia.
Introduction
Carotid body (CB) chemoreceptor cells and pulmonary artery smooth muscle cells (PASMC) detect hypoxia with a very low threshold (PO 2 70-75 mmHg) (Gonzalez et al., 1994; Marshall et al., 1994) generating adaptive responses (Richalet, 1997; Gonzalez, 1998) . In both cell types the hypoxic transduction cascade involves inhibition of O 2 -sensitive K + channels, activation of voltage operated Ca 2+ channels, and generation of Ca 2+ -dependent responses (López-Barneo et al., 1988; Post et al., 1992; Gonzalez et al., 2002) . In CB chemoreceptor cells, final output of the hypoxic transduction cascade is the Ca 2+ -dependent release of neurotransmitters, and the magnitude of neurotransmitter release response is proportional to the intensity of hypoxia Montoro et al., 1996; Vicario et al., 2000) . In both cell types it has been proposed that reactive oxygen species (ROS) play a critical role linking low PO 2 to K + channel inhibition.
For CB chemoreceptor cells Acker (1994) proposed that the O 2 -sensor would be a phagocyte-like NADPH oxidase, which inhibited by hypoxia would cause a decrease in the rate of ROS production; decreased ROS levels would increase the cellular GSH/GSSG ratio, and thereby a reduction of S S bridges in the K + channel protein, leading to the observed inhibition of K + channels. Later on, Obeso et al. (1999) and by He et al. (2005) found, respectively, that maximal pharmacological inhibition of NADPH oxidase did not abolished the release of neurotransmitters elicited by hypoxia in chemoreceptor cells and that NADPH oxidase knockout mice cells exhibited normal or even exaggerated sensitivity to hypoxia. More recently it has been suggested that in chemoreceptor cells hypoxia would increase (Chandel and Schumacker, 2000) or decrease mitochondrial ROS production (Porwol et al., 2001) . Mitochondria would represent the O 2 -sensor, and altered levels of mitochondrial ROS would gain cell cytoplasm to oxidize SH or to reduce S S groups in K + channels leading to their inhibition. Along these lines, increased mitochondrial ROS production has been implicated in the long-term facilitation of the CB function produced by intermittent hypoxia (Peng et al., 2003) .
In the case of PASMC it has also been published that modulation of the rate of mitochondrial ROS production plays a role in the hypoxic inhibition of K + channels. There are also two diametrically opposed views: that hypoxia increases mitochondrial ROS (Waypa et al., 2001; Waypa and Schumacker, 2006) and that hypoxia decreases mitochondrial ROS (Archer et al., 1999; Moudgil et al., 2005) . Implications derived from these opposed views are that an augmentation or a diminution of mitochondrial ROS are the factors coupling hypoxia to K + channel inhibition in PASMC.
These uncertainties regarding the significance of mitochondrial ROS in O 2 -sensing have prompted the present study. We have used several mitochondrial blockers and the uncoupler dinitrophenol (DNP) to modify the rate of mitochondrial ROS production and have concomitantly studied the function of chemoreceptor cells. We have assessed the rate of ROS production by measuring tissue levels of reduced and oxidized glutathione (GSH and GSSG respectively) and deriving the glutathione redox potential (E GSH ) (Schafer and Buettner, 2001 ). The activity of chemoreceptor cells was measured as their rate of catecholamine (CA) release (Gonzalez et al., 1994) ; we also measured ATP content in the CB. The experimental setup was as follows: different concentrations of each mitochondrial poison were tested for their ability to alter E GSH on rat diaphragms, and selected concentrations capable of altering the E GSH , were used to study their effects on the release of CA and ATP content. We also tested the effect of the antioxidant N-Acetylcysteine (NAC), a known precursor for glutathione synthesis and ROS scavenger, on the redox balance and CB responses.
Material and methods

Surgical procedures
Removal and dissection of rat diaphragm
Adult Wistar rats of both sexes (body weight 250-300 g) were anaesthetized with sodium pentobarbital (60 mg/kg, i.p.) dissolved in physiological saline. Diaphragm was removed and placed in a lucite chamber filled with ice-cold 100% O 2 saturated Tyrode (in mM: NaCl, 140; KCl, 5; CaCl 2 , 2; MgCl 2 , 1.1; glucose, 5.5; HEPES, 10; pH 7.40 with 1N NaOH). Under a dissecting microscope, the diaphragm was cleaned and cut in four quadrants, each constituting an experimental sample.
Removal and dissection of rat CB
Under the same anesthesia a longitudinal incision was made in the ventral surface of the neck. This permitted the location of carotid arteries, and the dissection of the carotid bifurcation region, which was then placed in a lucite chamber. With the aid of a dissecting microscope the CB was identified and cleaned of connective tissue. Animals were killed by an intracardiac overdose of Na-pentobarbital. Protocols were approved by the Institutional Committee of the University of Valladolid for Animal Care and Use.
Measurement of GSH and GSSG levels
Tissue incubation
Each of the four segments of the diaphragm was placed in a glass scintillation vial containing 10 ml of bicarbonate-buffered Tyrode (composition as before except for the substitution of 24 mM NaCl with 24 mM of NaHCO 3 ) and kept in a metabolic shaker bath at 37 • C. They were initially incubated for 30 min in Tyrodebicarbonate equilibrated with 21% O 2 /5% CO 2 allowing the tissue to recover from the dissection stress and thereby assuring uniformity of conditions throughout the samples. This incubating solution was discarded and replaced by fresh control solution or solutions containing the different metabolic poisons at concentrations specified in Section 3; in most of the experiments this incubation lasted 10 min. Incubating vials were continuously bubbled with the gas mixture saturated with water vapor. At the end of the incubation, the samples were placed for 5 min in new glass vials containing 10 ml of ice-cold Tyrode equilibrated with 100% O 2 . Tissues were dry-blotted on filter paper, weighed and placed in eppendorf tubes with a solution of 5-sulfosalicylic acid (SSA) at 5% containing 0.25 mM EDTA; SSA solution volume was adjusted to 5× tissue weight. Tissues were glass to glass homogenized at 0-4 • C or stored at −80 • C until assay (Gonzalez et al., 2004b) . Homogenates were centrifuged (4 • C, 10 min) and the supernatant was used to measure GSH/GSSG.
GSH and GSSG assays
The measurement of GSH and GSSG was made with the method of Griffith (1980) as described in detail (Gonzalez et al., 2004b) . Spontaneous reduction of 5,5 -dithiobis-(2-nitrobenzoic acid) (DTNB) by GSH generates 5-thio-2-nitrobenzoic acid (TNB; peak absorbance at 412 nm) and GSSG. The GSSG formed is backreduced enzymatically to GSH by glutathione reductase coupled to NADPH oxidation. This enzymatic step makes the assay highly specific, and cycling renders it very sensitive (10 −10 mol/assay). Reactant concentrations (DTNB, NADPH and glutathione reductase) were selected to obtain a linear rate of color formation during 2-3 min. The slope of the linear color formation (absorbance/min) is directly proportional to the glutathione in the sample. Assaying standards with different amounts of GSH and plotting absorbance change as a function of time yield several lines with different slopes. The plot of slopes of these lines as a function of the GSH used is also linear and defines the standard curve. This standard curve allows calculation by interpolation of the concentrations of total glutathione (GSt = GSH + GSSG) in the problem samples. To specifically determine GSSG, the GSH present in the supernatants is destroyed with 2-vinylpyridine and later assayed as before, except for the use of sample and glutathione reductase amounts due to the lower concentration of GSSG in the tissues. Standard and problem samples were assayed in triplicate. In problem samples, the concentration of GSH is obtained as the difference GSt − GSSG. The standard curves to measure GSt and GSSG are usually prepared with GSH because the enzymatic cycling makes it irrelevant to start with GSH or GSSG. It should be noted that each molecule of GSSG yields two molecules of GSH and therefore, when we determine GSt in the tissue we are actually measuring GSH + 0.5 GSSG, and when we are measuring GSSG we are in fact measuring half its molar concentration. Adequate corrections were made when plotting the data. Glutathione redox potential (E GSH ) was calculated as a Nernst potential (Schafer and Buettner, 2001 ).
Catecholamine release by the CB
Isotopic labeling of CA deposits in the CB
Deposits of CA present in chemoreceptor cells were labeled by incubating the organs with 3 H-tyrosine, the natural precursor of CA. The intact CBs were incubated in small glass vials (37 • C; 2 h; in a shaking bath) containing 0.5 ml of Tyrode solution. The incubating solution contained 3,5-3 H-tyrosine (30 M; 45 Ci/mmol; Amersham, Spain) and 100 M 6-methyl-tetrahydropterine and 1 mM ascorbic acid, cofactors for tyrosine hydroxylase and dopamine-␤-hydroxylase, respectively ; usually 8 CBs were incubated simultaneously.
3 H-CA release measurement
After the labeling period, CBs were individualized in glass scintillation vials kept at 37 • C in a metabolic shaker containing 4 ml of precursor-free Tyrode solution. Solutions were continuously bubbled with 20%O 2 /5%CO 2 (balanced with N 2 ) saturated with water vapor. During the first hour of incubation, solutions were collected every 20 min and discarded. Thereafter, incubating solutions, both control and drug-containing, were collected every 10 min and saved for analysis of their 3 H-CA content. They were collected in glass scintillation vials and, to prevent degradation of the 3 H-CA released, they were acidified to pH 3 by the addition of glacial acetic and ascorbic acid and maintained at 4 • C. Finally CB tissues were homogenized (0.4N perchloric acid; 1 ml), centrifuged for 10 min and the supernatant stored for 3 H-CA analysis. 3 H-CA were adsorbed into alumina at alkaline pH (8.6), bulk eluted with 1 ml of 1N HCl and quantified by liquid scintillation counting.
Measurement of ATP content
Since ATP levels in tissues are very labile and potentially altered by experimental manipulations, special precautions were taken to perform all the assays in strictly identical conditions (Obeso et al., 1986 (Obeso et al., , 1989 . Briefly, after surgical removal and cleaning, CBs were incubated in Tyrode-bicarbonate at 37 • C and continuously bubbled with 20%O 2 , 5%CO 2, 75%N 2 saturated with water vapor for 20 min. This initial incubation solution was discarded and replaced by a new one, either control or drug-containing solution and the incubation proceeded for an additional 10 min. At the end of the incubation CBs were placed on pre-cooled (−20 • C) homogenizer pestles and homogenized (glass to glass) in ice-cold 0.6N PCA (100 l). The samples were then centrifuged at 4 • C, the supernatants neutralized with 2.4N potassium bicarbonate, and after 20 min centrifuged again. ATP was measured in these last supernatants by a bioluminescence luciferine-luciferase assay (FLE50, Sigma). For ATP quantification 100 l of sample supernatants were added to 2 ml of buffer (20 mM HEPES, 5 mM NaHPO 4 , 25 mM MgCl 2 , pH 7, 4) at room temperature. The reaction begins when the enzyme is added to the mixture. The samples were analyzed for 1 min by bioluminescence using a luminescence counter (Beckman). Quantification of endogenous ATP levels in the CB was calculated by interpolation in standard curves.
Drugs
The following mitochondrial poisons were used in the present study: rotenone (Rot, blocker of complex I), 3-nitropropionic acid (3-NP, blocker of complex II), antimycin A (AA, blocker of complex III), sodium azide (SA, blocker of complex IV), and the mitochondrial uncoupler 2,4-dinitrophenol (DNP). We have also used N-acetylcysteine (NAC), which is a precursor for glutathione synthesis and ROS scavenger. All drugs were obtained from Sigma (Madrid, Spain).
Statistics
Data are expressed as mean ± SEM and compared for statistical significance using a two tails Student-t-test for unpaired data. Significance level was established at p < 0.05.
Results
Effects of mitochondrial blockers and DNP on ROS production in rat diaphragm
Selection of mitochondrial poisons concentrations. The size of the CB (≈50 g) (Vicario et al., 2000) precludes its use for measuring GSH and GSSG and for deriving E GSH (Gonzalez et al., 2004a) . Therefore, we used diaphragm to test the effects of mitochondrial poisons on E GSH , and based upon these, concentrations for use in the CB were selected. Fig. 1 shows findings obtained in response to different concentrations of rotenone, a blocker of the complex I. In the upper and middle panel are shown, respectively, the levels of GSH and GSSG present in the diaphragm in control conditions, in diaphragms incubated with 1 M rotenone and in diaphragms incubated with 1 M rotenone + 2 mM NAC. GSH levels in control tissues were 0.49 mol/g fresh tissue with GSSG levels amounting to 0.020 mol/g fresh tissue. Rotenone 1 M caused a tendency for GSH to decrease to 0.41 mol/g and a tendency for GSSG to increase to 0.021 mol/g. Preincubation (10 min) of the diaphragms with 2 mM NAC immediately prior to and during the incubation with 1 M rotenone altered the effects induced by rotenone (GSH rose to 0.43 and GSSG decrease to 0.018 mol/g). The lower panel shows mean E GSH potentials in control conditions, in the presence of NAC (2 mM), in the presence of different concentrations of rotenone and in the presence of 1 M rotenone + 2 mM NAC. As expected NAC significantly increased control E GSH from −181 ± 1.5 to −186 ± 1.5 mV (p < 0.05). Rotenone at concentrations of 100 and 250 nM did not alter the E GSH , but at 1 M decreased it to −175 ± 2 mV (p < 0.05). Rotenone (1 M) in NAC preincubated tissues yielded E GSH of −179 ± 2.5 mV, not different from control. Fig. 2 shows E GSH observed in diaphragms incubated with different mitochondrial poisons in the absence (top panel) and in the presence of 2 mM NAC (bottom panel); for comparative purposes both panels include data from control, NAC-treated and rotenone + NAC treated tissues described in Fig. 1 . 3-NP a specific inhibitor of succinate-coenzyme Q reductase (complex II) at a concentration of 2 mM induced minor changes in GSH and GSSG levels and E GSH potential, but increasing incubation time (30 min) and concentration (5 mM), significantly decreased GSH and increased GSSG concentrations, and consequently E GSH potential decreased −160 mV; p < 0.01 vs. control). Antimicyn A is a blocker of the coenzyme Q-cytochrome c reductase (complex III), which at a concentration of 0.2 g/ml caused a very significant decrease of E GSH to −165 ± 2 mV (p < 0.001). No additional concentrations of antimicyn A were tested. Sodium-azide, a blocker of cytochrome c oxidase (complex IV), was tested at concentrations of 1, 5 and 10 mM. Sodium azide (1 mM) produced a minor decline in E GSH that did not reach statistical significance when compared with control tissues. As plotted in Fig. 2 , 5 mM sodium azide decreased the E GSH to −163 ± 1.5 mV (p < 0.001). A higher concentration (10 mM) further decreased E GSH to −160 ± 1.5 mV (p < 0.001; not shown).
The mitochondrial uncoupler DNP was tested at concentrations of 100 (plotted in the figure), 250 and 1000 M. DNP did not alter E GSH at none of the concentrations used. Bottom panel of Fig. 2 shows results obtained in parallel experiments in which mitochondrial poisons were tested in tissues treated with 2 mM NAC. This antioxidant reversed the oxidative effect of blockers of the electron transport chain on E GSH ; NAC did not modify E GSH levels in DNP treated tissues. Concentrations of mitochondrial poisons shown in Fig. 2 were used in the rest of experiments. Fig. 3 shows the capacity of rotenone to activate chemoreceptor cells and their release of 3 H-CA; this figure also aims to illustrate the general protocol of the release experiments. The upper panel of Fig. 3 shows the time course of the 3 H-CA release response elicited by 250 nM and 1 M rotenone. Rotenone applied for 10 min elicited a prompt release that declined slowly to basal levels upon incubation with rotenone-free solutions; note also that treatment with NAC (10 min before and during rotenone application) did not alter the time course of the 3 H-CA release response elicited by 250 nM and 1 M rotenone. The bottom panel shows the accumulated release response, equivalent to the area under the curves in previous panel, elicited by 100, 250 and 1000 nM rotenone in the absence and in the presence of NAC. In addition to a clear dose dependence of rotenone action, data also indicate that the release response elicited by rotenone is not affected by the treatment with the antioxidant. Fig. 4 shows a summary of the accumulated 3 H-CA release responses elicited by different mitochondrial poisons in the CB chemoreceptor cells (top); the bottom part of the figure shows release responses elicited by the same drugs in CBs treated with 2 mM NAC. All mitochondrial poisons were applied for 10 min, except 3-NP that was applied for 30 min. Concentrations of drugs were those represented in Fig. 2, i.e., 1 M rotenone, 5 mM 3-NP, 0.2 g/ml antimycin A, 5 mM sodium azide and 100 M DNP; as in previous experiments NAC was applied 10 min before and during mitochondrial poisons application. 3-NP elicited a very small release response that barely doubled the 3 H-CA basal release obtained in the absence of any drug. On the contrary, antimycin A and sodium azide were potent stimuli that promoted a fast onset response with a slow recovery of basal release rates upon drug removal. DNP at the concentration plotted produced a moderate release response, but higher concentrations produced a dosedependent increase in the secretory response (Obeso et al., 1989) . Treatment of CBs with the antioxidant did not modify the 3 H-CA release elicited by any of the mitochondrial poisons (bottom panel).
Effects of mitochondrial blockers and DNP on the release of 3 H-CA from CB chemoreceptor cells
Effects of mitochondrial blockers and DNP on the CB ATP content
Classical mitochondrial poisons are stimulants of the CB chemoreceptors in any preparation tested, from intact animal to isolated organs and isolated cells. O 2 -sensing and hypoxia generated responses have been linked to mitochondria and electron transport chain-ATP synthesis, albeit in different manners (Mulligan and Lahiri, 1982 vs. Obeso et al., 1989; Ortega-Sáenz et al., 2003 vs. Wyatt and Buckler, 2004) . The apparent lack of correlation between ROS production and chemoreceptor cell activation exhibited by mitochondrial poisons (e.g., experiments with and without NAC), prompted a group of experiments aimed to verify that at the concentrations tested, mitochondrial poisons were indeed effective mitochondrial agents in the CB. Top panel of Fig. 5 shows that basal ATP concentration in the rat CB was 1.46 ± 0.07 mol/g of fresh tissue. Rotenone applied for 10 min at a concentration of 1 M decreased the CB ATP content to around 1/3 of the control level (0.51 ± 0.09 mol/g of fresh tissue). 3-NP (5 mM; 30 min) did not alter ATP levels in the CB. Antimycin A (10 min; 0.2 g/ml) decreased ATP levels to nearly 50% (0.77 ± 0.09 mol/g), and the concentration of sodium azide tested (5 mM, 10 min) was also very effective in reducing ATP levels in the CB. The uncoupler DNP (100 M) did not decrease ATP levels (1.46 ± 0.09 mol/g of fresh tissue), however, increasing the concentration to 500 M reduced ATP to 0.81 ± 0.06 mol/g of fresh tissue (not shown). The bottom panel of Fig. 5 demonstrate that NAC per se neither modified the ATP content in control CBs nor altered the effects induced by mitochondrial poisons.
Discussion
The aim of the present study has been to search for a link between levels of mitochondrial-derived ROS and the activity in chemoreceptor cells. To alter mitochondrial ROS production we have used several blockers of the respiratory chain and the mitochondrial uncoupler DNP, and assessed ROS production as the change in E GSH . Our findings on mitochondrial ROS production conform to current literature: blockers of the respiratory chain cause a decrease in E GSH , albeit with different potencies, while the uncoupler did not measurably alter ROS production (Votyakova and Reynolds, 2001; Sipos et al., 2003) . Additionally, and also in accord with literature (Kim et al., 2004; Zhang et al., 2004; Wang et al., 2006; Hu et al., 2007 ) the oxidative status produced by mitochondrial inhibition is prevented by incubation of tissues with NAC. Selected concentrations of mitochondrial poisons, effective to decrease E GSH , also activated CB chemoreceptor cells eliciting the release of neurotransmitters. Finally, the same doses of mitochondrial poisons caused a decrease of ATP levels in the CB. The last two responses, neurotransmitter release and ATP decrease, were not affected by NAC treatment indicating that their genesis is independent of the general redox status of chemoreceptor cells.
We selected rat diaphragm to assess the effects of mitochondrial poisons on ROS production because we previously founded that contained similar GSH/GSSG content and redox capacity than calf CB (Sanz-Alfayate et al., 2001; Gonzalez et al., 2004a) and the thickness of the tissue, comparable to that of the CB (< 1 mm), assured similar drugs and gas diffusion than rat CB.
Our study was designed to work with freshly isolated intact CBs to avoid potential phenotypic changes of simplified preparations such as primary tissue cultures (Gauda, 2002; Conde et al., 2007) . We have selected a fingerprinting method to measure ROS production, i.e., E GSH , because it is a reliable method (Schafer and Buettner, 2001 ) free of the uncertainties derived of the use of fluorescent indicators (Moudgil et al., 2005; Waypa and Schumacker, 2005) .Rotenone was tested at three different concentrations in the diaphragm to assess E GSH and in the CB to assess the effect on the chemoreceptor activity (release of 3 H-CA), and in both tissues, in the absence and in the presence of the antioxidant NAC. Results indicate a lack of correlation between both parameters measured. Rotenone was effective to alter E GSH exclusively at the highest tested concentration (1 M) and yet it produced a dose-dependent activation of chemoreceptor cells from 0.1 to 1 M. It might be argued that due to mitochondrial differences between diaphragm and CB, rotenone was indeed capable of decreasing E GSH in the CB at the lower concentrations. If this were the case a parallelism (and potential causal relationship) between decrease in E GSH (or increased ROS) and the activity of the cells might exist. However, NAC was able to reverse the oxidative status produced by the highest concentration of rotenone in diaphragm, rendering most plausible that if lower rotenone concentrations have produced any oxidative status in chemoreceptor cells it also would be normalized by NAC. As mentioned above, NAC is very effective in this regard due to its double effect as H 2 O 2 scavenger and GSH precursor (Villagrasa et al., 1997) , and in fact the increase in E GSH produced in diaphragm and calf CB was nearly identical (Sanz-Alfayate et al., 2001) . In sum, rotenone activates chemoreceptor cells by a mechanism unrelated to mitochondrial ROS production and the E GSH of the cells.
The intimate mechanism mediating the mitochondrial production of superoxide by 3-NP is controversial (Bacsi et al., 2006 ). Yet, it is well established that 3-NP is an irreversible inhibitor of succinate dehydrogenase capable of producing marked amounts of superoxide and oxidative damage when applied to isolated cell systems or injected in intact animals (Bacsi et al., 2006; Herrera-Mundo et al., 2006) . There are many studies indicating that the neurotoxic manifestations of 3-NP injections are prevented or ameliorated by concomitant antioxidant treatment (Nam et al., 2005) and attenuated in transgenic mice overexpressing superoxide dismutase (Beal et al., 1995) . It is worth noting that the observed acute neurotoxic manifestations of 3-NP injection in rats which represent early markers of oxidative stress, were fully prevented by prior administration of the antioxidant S-allylcysteine (Herrera-Mundo et al., 2006) , conforming present findings in intact tissue in vitro where the decrease of the E GSH was reversed by treatment with NAC. However, although 3-NP was more effective that rotenone altering the E GSH it was almost incapable of activating chemoreceptor cells, and this limited effectiveness in promoting neurosecretion in chemoreceptor cells was not modified by NAC treatment. Our findings with 3-NP fail to show a link between mitochondrial ROS production and chemoreceptor cell activation.
Antimycin A and sodium azide, inhibitors of complex III and IV, respectively, produced as expected a marked decrease in E GSH (Votyakova and Reynolds, 2001; Turrens, 2003; He et al., 2005) , and both of them were powerful stimulants of neurosecretion in chemoreceptor cells. Then, a parallelism between ROS production and chemoreceptor cell activity was apparent for these two blockers of the respiratory chain. However, treatment of the tissues with NAC fully reversed the E GSH to normality, but normalization of the redox status did not modify their neurosecretory power. These last observations coupled to the well known ability of NAC to buffer the increased production of ROS induced by complex III and IV inhibitors in many cell systems (Watabe and Nakaki, 2007; Stöckl et al., 2006; Suzuki et al., 1998; Satpute et al., 2008; Zhang et al., 2007) , would indicate that there is not any relationship between ROS levels and chemoreceptor cell activity.
As expected DNP did not modify the E GSH because it is known that uncouplers per se do not increase the rate of ROS production (Votyakova and Reynolds, 2001) . Then it would appear that DNP does not activate chemoreceptor cells via modification of the redox status of the cells.
On discussing present findings on the redox changes produced by metabolic poisons, we want to link them to previously published data using low PO 2 . In Sanz-Alfayate et al. (2001) we tested 21% O 2 (normoxia) vs. 5% O 2 (moderately intense hypoxia) on calf CBs and found that the E GSH were, respectively, −186.9 ± 1.1 and −184.5 ± 1.2. Additionally, we showed that NAC increased significantly normoxic E GSH to −201.1 ± 1.1. Sanz-Alfayate et al. (2001) also showed that hypoxia increased normoxic release by a factor of 3-5 and NAC neither modified normoxic nor hypoxic release response. Thus, as it is the case with metabolic poisons, these data with different O 2 tensions and NAC indicate that the response of chemoreceptor cells to the natural stimuli is neither linked to the redox status of the cells.
A general consideration should be made, namely where or how do mitochondrial poisons act to generate an activation of chemoreceptor cells. As discussed above we exclude ROS/general redox status of cells as a common denominator of poisons to activate chemoreceptor cells. Below we discuss a possible link between metabolic poisons effects on energy charge of the cells and their activation. Yet, we cannot exclude that mitochondrial poisons have neither ROS nor energy charge related effects that can afford or contribute to the observed activation of chemoreceptor cells that they produce. In this regard, it should be mentioned that Ortega-Sáenz et al. (2003) have suggested that rotenone activates chemoreceptor cells by a mechanism independent of mitochondrial respiratory chain and proposed that chemoreceptor cells express a rotenonesensitive molecule that is critical for O 2 -sensing.
As stated in the Section 3, the measurement of ATP in the CB served the main purpose of demonstrating that concentrations of mitochondrial poisons used to activate CB chemoreceptor cells were indeed interfering with mitochondrial function in this organ. As a general rule, inhibition of electron transport chain should be expected to produce parallel increases in ROS generation and decreases in ATP genesis. Indeed, this was the case for rotenone, antimicyn A and sodium azide. These inhibitors of the respiratory chain increased ROS production (decreased E GSH ) and produced parallel decreases on ATP levels in the CB. The ROS scavenging action of NAC corrects the altered E GSH , but the antioxidant could not prevent the blockade of transference of electrons caused by mitochondrial blockers, and thereby could not reverse the decrease in ATP synthesis (Watabe and Nakaki, 2007) . In sum, the decrease in ATP levels in the CB produced by rotenone, antimicyn A and sodium azide indicate that indeed they are generating ROS in chemoreceptor cells. However, contrary to the situation with inhibitors of complexes I, III and IV, we have found that blockade of complex II with 3-NP caused a marked decrease in E GSH without altering ATP levels. It should be mentioned that in intact neurons 3-NP augments mitochondrial production of ROS without substantially altering ATP levels, energy charge of cells and mitochondrial membrane potential (Del Río et al., 2007; Franceschini et al., 2006; García and Massieu, 2003) . Then, it appears that in those preparations, as well as in our intact CB preparation, the situation is alike that found in isolated mitochondria fuelled with substrates entering at complex I where 3-NP neither modified the respiration rate nor the respiratory control (Pandey et al., 2007) . DNP (100 M) did not modify ATP levels in the rat CB, conforming previous findings in the cat CB (Obeso et al., 1989) . Since DNP produced a concomitant increase in glucose utilization in the cat CB, the interpretation was that the partial uncoupling effect of this moderate concentration of DNP was compensated by an increased respiration rate capable of maintaining ATP levels (Obeso et al., 1989) . Aside from the activation of respiration, at the highest concentration tested in the present study (500 M), the uncoupling action of DNP would be large enough as to decrease the driving force for mitochondrial ATPase below the critical level necessary to support the rate of ATP synthesis required to maintain normal ATP levels. Changes in ATP levels have been proposed to play a role in coupling cellular energy status to background K + channel activity and chemoreceptor excitability. However the direct modulation by nucleotides is not the only link between energy metabolism and channel activity; other cytosolic factors also play a role in determining channel activity since significant rundown occurs upon patch excision even in the presence of high levels of MgATP (Varas et al., 2007) . Overall, and although not specifically addressed in present study, our measurements of ATP would be consistent with the proposal that mitochondrial poisons activation of chemoreceptor cells could be mediated by AMP kinase-dependent inhibition of K + channels in chemoreceptor cells . In fact, these authors have observed in isolated type I cells that pharmacological activation of AMP kinase lead to plasma membrane depolarization and Ca 2+ influx, and in the intact CB-carotid sinus preparation increased chemosensory fiber discharge. They also showed that the AMP kinase antagonist compound C reversed the effects of hypoxia on chemoreceptor cell activation.
In sum, our study does not support the existence of a causal link between the levels of mitochondrial-derived ROS and activity of chemoreceptor cells. It is possible to activate chemoreceptor cells with agents that do not modify mitochondrial ROS levels (low concentrations of rotenone and DNP) and with agents that do increase ROS production (highest rotenone concentration, antimycin A and sodium azide); finally, there are mitochondrial poisons (3-NP) that causing an increase in mitochondrial ROS do not activate chemoreceptor cells. The deviations of ROS levels produced by mitochondrial agents were in all instances corrected by treatment with the antioxidant NAC, and yet the effectiveness of the mitochondrial agents to activate CB chemoreceptor cells remained unaltered. However, because signal transduction reactions are localized processes (Forman et al., 2004) , our conclusions do not exclude that specific redox signalling reactions might be linked to oxygen sensing in chemoreceptor cells.
